Dendreon Corp Receivables Turnover Ratio (DNDN), from the third quarter 2014 to the third quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dendreon Corp  (DNDN)
 

Dendreon Accounts Receivables Turnover Ratio from the third quarter 2014 to the third quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Dendreon Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2014 to a ratio of 10.61, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2014. Average receivable collection period, for the Dendreon in Sep 30 2014 quarter, has decreased to 34 days, compared to 39 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 132 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1018 to 1610.

What is Receivable Turnover Ratio?
What is Dendreon Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DNDN Receivables Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Receivable Change -40.67 % -17.09 % -30.44 % -11.12 % -9.39 %
Y / Y Revenue Change 7.53 % 12.13 % 1.75 % -12.47 % -12.79 %
Receivable Turnover Ratio (TTM) 10.61 9.27 8.57 7.83 7.89
DNDN's Total Ranking # 1610 # 1018 # 1022 # 1158 # 1610
Accounts Receivable average collection period days 34 39 43 47 46
Seq. Receivable Change -32.05 % 11.41 % -21.29 % -0.44 % -5.04 %
Seq. Revenue Change -11.05 % 19.53 % -8.09 % 10.05 % -7.25 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 133
Overall Market # 1610

Receivable Turnover Ratio Statistics
High Average Low
0.78 0.54 0.4
(Sep 30 2014)   (Dec 31 2012)





DNDN Company Profile • Back to DNDN Efficiency Comparisons • Compare DNDN Receivables Turnover Ratio to its Competitors

Financial Statements
Dendreon's Accounts Receivable $ 21 Millions Visit DNDN's Balance sheet
Dendreon's Sales TTM $ 299 Millions Visit DNDN's Income Statement
Sources of DNDN's Revenues Visit DNDN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DNDN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DNDN's Growth Rates DNDN's Roa DNDN's Inventory Turnover Ratio DNDN's Dividend Comparisons
DNDN's Profitability Ratios DNDN's Roi DNDN's Asset Turnover Ratio DNDN's Dividend Growth
DNDN's Valuation Ratios DNDN's Roe DNDN's Financial Strength Ratios DNDN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Nature s Sunshine Products inc   37.92 $ 378.218  Millions$ 9.974  Millions
Alnylam Pharmaceuticals Inc   32.16 $ 39.272  Millions$ 1.221  Millions
Interpace Biosciences Inc   31.17 $ 141.360  Millions$ 4.536  Millions
Wearable Health Solutions, Inc.  30.64 $ 1.160  Millions$ 0.038  Millions
Seelos Therapeutics inc   30.43 $ 7.652  Millions$ 0.252  Millions
Brookdale Senior Living Inc   29.81 $ 3,313.836  Millions$ 111.172  Millions
Ernexa Therapeutics Inc   29.74 $ 25.871  Millions$ 0.870  Millions
Oragenics Inc   29.51 $ 1.154  Millions$ 0.039  Millions
Harrow Inc   29.50 $ 1.113  Millions$ 0.038  Millions
Immunogen inc   29.46 $ 55.881  Millions$ 1.897  Millions
Fonar Corporation  28.42 $ 69.659  Millions$ 2.451  Millions
American Cryostem Corporation  28.19 $ 0.121  Millions$ 0.004  Millions
Veracyte Inc   26.56 $ 32.829  Millions$ 1.236  Millions
Cyteir Therapeutics Inc   25.45 $ 2,002.800  Millions$ 78.700  Millions
Cba Florida Inc   23.68 $ 5.696  Millions$ 0.241  Millions
Macrogenics Inc   19.55 $ 57.227  Millions$ 2.927  Millions
Sunlink Health Systems Inc   19.37 $ 105.047  Millions$ 5.423  Millions
Intelgenx Technologies Corp   17.96 $ 1.235  Millions$ 0.069  Millions
U s Stem Cell Inc   17.93 $ 1.471  Millions$ 0.082  Millions
Vanda Pharmaceuticals Inc   17.79 $ 43.570  Millions$ 2.449  Millions
Ethema Health Corporation   17.77 $ 5.852  Millions$ 0.329  Millions
Oncologix Tech Inc.  17.77 $ 3.677  Millions$ 0.207  Millions
Vivosim Labs Inc   17.73 $ 0.399  Millions$ 0.023  Millions
Gt Biopharma Inc   17.60 $ 0.330  Millions$ 0.019  Millions
Abeona Therapeutics Inc   17.59 $ 0.853  Millions$ 0.049  Millions
Statera Biopharma Inc fka Cytocom Inc   17.16 $ 6.183  Millions$ 0.360  Millions
China Biologic Products Holdings Inc   17.16 $ 227.857  Millions$ 13.278  Millions
Pacific Biosciences Of California Inc   16.57 $ 52.824  Millions$ 3.189  Millions
International Stem Cell Corporation  16.54 $ 6.935  Millions$ 0.419  Millions
Nektar Therapeutics  15.96 $ 212.301  Millions$ 13.301  Millions

Date modified: 2026-09-08T15:07:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.